Oral Abstract Session:
32. Tuberculosis and other Mycobacterial Infections
Thursday, October 4, 2018: 8:45 AM-10:00 AM
Room: W 2002

Tracks: Global ID, Adult ID


Moderators:  Sarah Parker, MD, Children's Hospital Colorado/University of Colorado School of Medicine and Kevin L. Winthrop, MD, MPH, Oregon Health & Science University-PSU

Presentations:
8:45 AM
119
Prospective validation of a three-gene signature for tuberculosis diagnosis, predicting progression and evaluating treatment response
Hayley Warsinske, PhD; Aditya Rao, BA; Flora Martinez Figueira Moreira, BS; Paulo Cesar Pereira Dos Santos, BS; Andrew Liu, MS; Madeleine Scott, BA; Stephanus Malherbe, MD, PhD; Katharina Ronacher, PhD; Gerhard Walzl, PhD; Jill Winter, PhD; Timothy E. Sweeney, MD, PhD; Julio Croda, MD PhD; Jason R. Andrews, MD; Purvesh Khatri, PhD
9:00 AM
120
A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01E Vaccine against Pulmonary Tuberculosis Disease in Adults with Latent Mycobacterium tuberculosis Infection
Olivier Van Der Meeren, MD; Mark Hatherill, MD; Videlis Nduba, MBChB, MPH; Robert J. Wilkinson, FMedSci; Monde Muyoyeta, MBChB, PhD; Elana Van Brakel, MBChB, MSc; Helen M. Ayles, MBBS, PhD; German Henostroza, MD; Friedrich Thienemann, MD, MScIH, DTMPH; Thomas J. Scriba, PhD; Andreas Diacon, MD, PhD; Gretta L. Blatner, MS, MPH; Marie-Ange Demoitié, MSc; Michele Tameris, MBChB; Mookho Malahleha, MD, MPH; James C. Innes, MBChB, MSc; Elizabeth Hellstrom, MBChB; Neil Martinson, MBChB, MD, MPH; Tina Singh, MD; Elaine J. Akite, MSc; Aisha K. Azam, MBBS; Anne Bollaerts, MSc; Ann M. Ginsberg, MD, PhD; Thomas G. Evans, MD; Paul Gillard, MD; Dereck R. Tait, FRCPath
9:15 AM
121
Improving Predictive Value of Phase 2a TB Drug Development Models through PET/CT Imaging (NexGen EBA)
Yingda Xie, MD; Laura Via, Ph.D; Ray Chen, MD; Lori Dodd, Ph.D.; Ying Cai, MS; Paveen Paripati, MS; Lisa Goldfeder, CCRP; Jill Winter, PhD; Kriti Arora, PhD; Jing Wang, PhD; Veronique De Jagar, MD; Stephanus Malherbe, MD, PhD; Taeksun Song, Ph.D; Gerhard Walzl, PhD; Andreas Diacon, MD, PhD; Clifton Barry III, Ph.D
9:30 AM
122
All-cause Mortality Increased with Nontuberculous Mycobacterial Lung Disease in US Medicare
Theodore Marras, MD, FRCPC, MSc; Quanwu Zhang, PhD; Mehdi Mirsaeidi, MD, MPH; Christopher Vinnard, MD; Keith Hamilton, MD; Jennifer Adjemian, PhD; Gina Eagle, MD; Ping Wang, PhD; Raymond Zhang, MBA; Engels Chou, MS; Kevin L. Winthrop, MD, MPH

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.